Professional Documents
Culture Documents
ROTA Brief3 Burden SP 1
ROTA Brief3 Burden SP 1
EPIDEMIOLOGY
AND DISEASE
BURDEN
OF ROTAVIRUS
INTRODUCTION
Diarrhea is one of the world’s leading killers of rhea deaths occur.(1) While efforts to increase ORT
children, and rotavirus remains among the most use should continue, providing ORT to treat each
common causes of severe diarrhea in children episode of rotavirus diarrhea in resource-poor set-
under the age of 5 years worldwide. tings is challenging.
Rotavirus is a virus that causes gastroenteri- Because of the high transmissibility of the
tis, an inflammation of the stomach and intestines. disease—which is often spread person-to-person
Rotavirus primarily infects the small intestine, de- and through contaminated objects, surfaces, food
stroying the surface tissue and preventing the ab- and water—it is found everywhere, including in
sorption of nutrients, causing diarrhea. Typical high- and middle-income countries with advanced
symptoms can range from mild, watery diarrhea water and sanitation systems. In fact, nearly all
to severe diarrhea with vomiting and fever. children experience at least one rotavirus infec-
WHO-recommended treatment, such as zinc tion during the first two years of life in unvaccinat-
supplements, oral rehydration therapy (ORT) and ed populations.(2)
treatment with intravenous (IV) fluids, when need-
ed, can help rehydrate children until the intestine
can repair and recover. In low-income countries,
particularly in hard-to-reach areas where children
do not have timely access to such medical care, se-
vere disease can result in rapid dehydration, lead-
ing to electrolyte imbalance, shock and death. Yet
many of the world’s poorest children do not have
access to ORT, despite it being inexpensive and ef-
fective. ORT coverage hovers around 40% in many
of the places where the greatest number of diar-
1
SEVERE DIARRHEAL
DISEASE IN
YOUNG CHILDREN
DUE TO ROTAVIRUS
While over 95 countries have introduced rotavi- Among 16 low- and middle-income countries in
rus vaccine into their national immunization pro- Asia, Africa, and Eastern Europe that had not in-
gram, an estimated 53%—over 70 million—of all cluded rotavirus vaccine in their national immu-
children globally remain unvaccinated.(3) Rotavi- nization programs as of 2016, a median of 40% of
rus was by far the most common pathogen found hospitalized cases of diarrhea in children less than
in a global review of studies of hospitalized diar- 5 years of age were due to rotavirus. In two coun-
rhea cases in countries that haven’t yet introduced tries—Afghanistan and the Democratic Republic
the vaccine, accounting for an estimated 38% of all of the Congo (DCR)—rotavirus accounted for two-
cases in children under 5.(4) Another global anal- thirds to three-quarters of all hospitalized cases of
ysis estimated that 27% of severe diarrhea world- diarrhea in children under 5 found at the surveil-
wide was due to rotavirus, with a range of 23–33% lance sites (Afghanistan later introduced rotavirus
by WHO region.(5) vaccines) (See Figure 2). These rates compared to
Rotavirus accounted for the highest propor- a median of 17.5% of hospitalized diarrhea due to
tion of cases of moderate to severe diarrhea in chil- rotavirus in 14 countries in the surveillance net-
dren under the age of 1 presenting at hospitals work that have introduced rotavirus vaccination
and health centers across sites participating in in their childhood immunization schedule, which
a seven-country prospective study (ranging from represents a greater than 50% difference.(8)
22–35% of cases) (See Figure 1).(6,7)
2
FIG. 1 CAUSES OF MODERATE TO SEVERE DIARRHEA AMONG CHILDREN
UNDER 2 ACROSS SEVEN AFRICAN AND ASIAN SITES(7)
Incidence per 100 child-years (Global Enteric Multicenter Study [GEMS] reanalysis)
Rotavirus
Adenovirus 40/41
Cryptosporidium spp
C jejuni/C coli
Shigella spp/EIEC
ST-ETEC
Norovirus GII
Astrovirus
Sapovirus
tEPEC
Shigella spp/EIEC
Rotavirus
Adenovirus 40/41
ST-ETEC
Cryptosporidium spp
Sapovirus
Astrovirus
C jejuni/C coli
Salmonella spp
H pylori
3
FIG. 2 PERCENT OF <5 DIARRHEA HOSPITALIZATIONS DUE TO ROTAVIRUS
IN COUNTRIES YET TO INTRODUCE THE VACCINE (2016)(8)
Countries 0 100
Afghanistan 74%
DRC 67%
Myanmar 46%
Cambodia 45%
Vietnam 45%
Indonesia 44%
Mongolia 42%
Lao PDR 41%
Nigeria 38%
Ukraine 34%
Uganda 32%
Nepal 25%
China 21%
Pakistan 19%
Azerbaijan 13%
Sri Lanka 12%
Among 373 children who experienced at least one rotavirus infection, over a period of 3 years
Number of
infections 12 3 4 5
% of children 8.9% 27.5% 36.7% 15.6% 11.4%
4
ROTAVIRUS DEATHS
IN CHILDREN
Rotavirus kills over 185,000 children under
5 every year and is responsible for over
one-third of all child diarrheal deaths.
Estimates of diarrheal deaths in children less than 5 children under 5.(13,17) In fact, even as the overall
years old have declined sharply in the past 15 years number of rotavirus deaths has fallen, the pro-
or so, from around 1.24 million worldwide in 2000 to portional contribution of rotavirus to all diarrheal
just over half a million in 2013.(16,17) This reduction is deaths has only slightly declined.(17) The sharpest
partially due to improvements in living conditions, reduction in the proportion of diarrheal deaths
including in water, sanitation, and hygiene, and due to rotavirus—from 36% in 2000 to 26% in
partially due to the use of new disease estimation 2013—occurred in Latin America, where nearly all
methods.(17) The estimated number of deaths from countries have included rotavirus vaccine in their
rotavirus in children under 5 also declined from national immunization program.
528,000 in 2000 to 215,000 in 2013—a nearly 60%
reduction. Models currently estimate that about Where are children dying of rotavirus?
185,300 children die annually from rotavirus.(13,17)
This recent decline is due to the revised estimates Nearly all rotavirus deaths occur in low- and mid-
of overall diarrheal deaths as well as to the introduc- dle-income countries.(13) In fact, in 2017, three
tion of rotavirus vaccine into many national immu- countries—Nigeria, India, and DRC—were esti-
nization programs since 2013.(18) mated to account for half of all rotavirus deaths.
Nonetheless, rotavirus remains a leading About three-quarters (73%) of all global deaths
cause of diarrheal deaths worldwide—accounting occurred in only 10 countries (see Figure 4).
for an estimated 35% of all diarrheal mortality in
Nigeria 30%
India 16%
DRC 7%
Chad 4%
Ethiopia 4%
Niger 3%
Indonesia 3%
Burkina Faso 2%
Angola 2%
South Sudan 2%
Other countries 27%
5
FIG. 5 RATES OF ROTAVIRUS MORTALITY PER 100,000 CHILDREN
UNDER AGE 5 IN 2017, BY COUNTRY(13)
6
Several of the countries with
the highest burden of rotavirus diarrhea
have recently introduced rotavirus
vaccination into their immunization
program nationally—such as Pakistan,
Ethiopia, and Angola—or in a phased
rollout, such as India. Others, such as
the Democratic Republic of the
Congo and Nigeria, have announced
plans to introduce the vaccine in the
next few years.
REFERENCES
1. UNICEF’s global database. Diarrhea data: 2014. 33: p. S19–S22. 18. Global Burden of Disease Collaborators,
Child health coverage 2015–2016. 2016; 10. Gladstone, B.P., et al., Protective effect Estimates of global, regional, and national
Available from: https://data.unicef.org/topic/ of natural rotavirus infection in an Indian morbidity, mortality, and aetiologies of
child-health/diarrhoeal-disease/. birth cohort. The New England journal of diarrhoeal diseases: a systematic analysis
2. Kotloff, K.L., The Burden and Etiology of medicine, 2011. 365(4): p. 337–46. for the Global Burden of Disease Study
Diarrheal Illness in Developing Countries. 11. Mustafa, A., et al., Baseline Burden of 2015. The Lancet. Infectious diseases, 2017.
2017. p. 799–814. Rotavirus Disease in Sudan to Monitor 17(9): p. 909–948.
3. International Vaccine Access Center, VIEW- the Impact of Vaccination. The Pediatric 19. Glass, R.I., et al., Rotavirus vaccines:
hub Report: Global vaccine introduction and Infectious Disease Journal, 2014. 33: Successes and challenges. Journal of
implementation. Johns Hopkins Bloomberg p. S23–S27. Infection, 2014. 68: p. S9–S18.
School of Public Health, 2018. 12. Bar-Zeev, N., et al., Effectiveness of a 20. Patel, M.M., et al., Global seasonality of
4. Lanata, C.F., et al., Global causes of monovalent rotavirus vaccine in infants rotavirus disease. Pediatric Infectious
diarrheal disease mortality in children <5 in Malawi after programmatic roll-out: Disease Journal, 2013. 32(4).
years of age: a systematic review. PLoS One, an observational and case-control study.
2013. 8(9): p. e72788. Lancet Infect Dis, 2015. 15(4): p. 422–428. ROTA Council thanks the following
5. Fischer Walker, C.L., et al., Global burden of 13. Global Burden of Disease Collaborative organizations for their support: Bharat
childhood pneumonia and diarrhoea. The Network. Global Burden of Disease Study Biotech, Bill & Melinda Gates Foundation,
Lancet, 2013. 381(9875): p. 1405–1416. 2017 (GBD 2017) Results. Institute for CDC, GSK, PATH, and Sabin Vaccine
6. Kotloff, K.L., et al., Burden and aetiology Health Metrics and Evaluation (IHME) Institute. Suggested Citation: ROTA Council
of diarrhoeal disease in infants and young 2018 2018; Available from: http://ghdx at International Vaccine Access Center
children in developing countries (the .healthdata.org/gbd-results-tool. (IVAC), Johns Hopkins Bloomberg School
Global Enteric Multicenter Study, GEMS): a 14. John, J., et al., Rotavirus gastroenteritis of Public Health. (2019). Rotavirus Disease
prospective, case-control study. The Lancet, in India, 2011–2013: Revised estimates and Immunization: The Epidemiology and
2013. 382(9888): p. 209–222. of disease burden and potential impact Disease Burden of Rotavirus.
7. Liu, J., et al., Use of quantitative molecular of vaccines. Vaccine, 2014. 32(S1): p. A5–A9.
diagnostic methods to identify causes of 15. Cortese, M., U. Parashar, and C. Centers Disclaimer: The presentation of maps
diarrhoea in children: a reanalysis of the for Disease, Prevention of rotavirus is not by any means an expression of
GEMS case-control study. The Lancet, 2016. gastroenteritis among infants and IVAC’s opinion regarding the legal status
388(10051): p. 1291–1301. children: recommendations of the Advisory of countries/territories, their governing
8. World Health Organization. WHO Global Committee on Immunization Practices authorities, or their official borders.
Invasive Bacterial Vaccine Preventable (ACIP). MMWR Morb Mortal Wkly Rep,
Disease and Rotavirus Surveillance Network 2009. 58(RR-2): p. 1–25. Photo credits:
Bulletin. 2017; Available from: https:// 16. WHO and Maternal and Child Epidemiology Page 6: Bill & Melinda Gates Foundation/
mailchi.mp/046b8f12e001/who-ib-vpd Estimation Group, Estimates of child cause Jiro Ose
-and-rotavirus-surveillance-bulletin-june of death, diarrhoea 2018. 2018.
-1566245?e=225412eff9. 17. Tate, J.E., et al., Global, Regional, and
9. Tagbo, B.N., et al., Epidemiology of National Estimates of Rotavirus Mortality
Rotavirus Diarrhea among Children Younger in Children <5 Years of Age, 2000–2013.
Than 5 Years in Enugu, South East, Nigeria. Clinical Infectious Diseases, 2016. 62(suppl
The Pediatric Infectious Disease Journal, 2): p. S96–S105.
7
THE EPIDEMIOLOGY
AND DISEASE BURDEN
OF ROTAVIRUS
KEY FACTS
Common
Rotavirus remains among the most common caus-
es of severe and fatal diarrhea in children under 5
worldwide and is the leading cause of severe and
fatal diarrhea in infants under 1. (See page 1)
Vulnerable
Children under 1 year of age suffer the highest
rates of rotavirus diarrhea and, in high-incidence
settings, a substantial proportion of cases occur
in children less than 6 months of age. (See page 2)
Deadly
An estimated 185,300 children died from rotavi-
rus in 2017 worldwide—nearly all in low- and mid-
dle-income countries. (See page 5)